within Pharmacolibrary.Drugs.ATC.D;

model D05AX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 13 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Calcipotriol (calcipotriene) is a synthetic derivative of vitamin D3 used primarily as a topical treatment for psoriasis. It modulates keratinocyte proliferation and differentiation and is approved for clinical use in several countries.</p><h4>Pharmacokinetics</h4><p>PK parameters are based on estimated data as no direct human systemic pharmacokinetic studies have been published due to the drug's topical use and low systemic absorption. Estimates relate to typical adult patients using the drug topically.</p><h4>References</h4><ol><li><p>Kragballe, K (1995). Calcipotriol: a new drug for topical psoriasis treatment. <i>Pharmacology &amp; toxicology</i> 77(4) 241–246. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-0773.1995.tb01020.x&quot;>10.1111/j.1600-0773.1995.tb01020.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8577633/&quot;>https://pubmed.ncbi.nlm.nih.gov/8577633</a></p></li><li><p>Berbis, P (2001). [Acitretine]. <i>Annales de dermatologie et de venereologie</i> 128(6-7) 737–745. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11460037/&quot;>https://pubmed.ncbi.nlm.nih.gov/11460037</a></p></li><li><p>Thiers, BH (1997). The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. <i>Journal of the American Academy of Dermatology</i> 37(3 Pt 2) S69–S71. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9344189/&quot;>https://pubmed.ncbi.nlm.nih.gov/9344189</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D05AX02;
